Global Liquid Biopsy Products Sales Market Report 2020

Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.

This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.
The sample type of Liquid Biopsy Products is Blood Sample, Urine Sample and Other Bio Fluids. The most proportion of sample type is Blood Sample, and the revenue proportion in 2015 is about 92%.

Market Analysis and Insights: Global Liquid Biopsy Products Market
The global Liquid Biopsy Products market size is projected to reach US$ 4976.7 million by 2026, from US$ 1273.7 million in 2020, at a CAGR of 25.5% during 2021-2026.

Global Liquid Biopsy Products Scope and Market Size
The global Liquid Biopsy Products market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Liquid Biopsy Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Liquid Biopsy Products market is segmented into
CTC
ctDNA
Exosomes

Segment by Application, the Liquid Biopsy Products market is segmented into
Blood Sample
Urine Sample
Other Bio Fluids

The Liquid Biopsy Products market is analysed and market size information is provided by regions (countries). Segment by Application, the Liquid Biopsy Products market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Liquid Biopsy Products Market Share Analysis
Liquid Biopsy Products market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Liquid Biopsy Products business, the date to enter into the Liquid Biopsy Products market, Liquid Biopsy Products product introduction, recent developments, etc.

The major vendors covered:
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc